APOE and Alzheimer disease: In vivo experiments on AD transgenic mouse models showed differences in Aβ deposition in an ApoE isoform-dependent manner: mice ApoE ε4-expressing had more than 10-fold fibrillar deposits compared to ApoE ε3 and ApoE ε2 mice (46, 49).